7,645.75

+31.75

+0.42%

52,123.00

+205.00

+0.39%

28,764.00

+230.00

+0.81%

Russell 2000 Futures

2,838.80

+17.50

+0.62%

4.9290

-0.0600

-1.20%

19.08

-0.34

-1.75%

3,913.40

+14.50

+0.37%

78,094.57

+114.56

+0.15%

Crude Oil Dec 26

99.73

-4.39

-4.22%

US Private Equity

10,850.63

-82.20

-0.75%

Canadian Sec - Delayed Quote CAD

TempraMed Technologies Ltd. (VIVI.CN)

0.3300 -0.0900 (-21.43%)

At close: October 30 at 3:55:32 PM EDT

Loading Chart for VIVI.CN

Chart Range Bar

Interval:

In partnership with ChartIQ

TempraMed Enters into Exclusive Kuwait Distribution Agreement, Expanding Gulf Region Commercial Footprint

TempraMed Enters into Exclusive Kuwait Distribution Agreement, Expanding Gulf Region Commercial Footprint

TempraMed Granted Mexican Patent for Newest Product, VIVI Box

TempraMed Granted Mexican Patent for Newest Product, VIVI Box

TempraMed Announces VIVI Cap Smart Connectivity with Apple Health and Google Fit, Providing Better Health Outcomes and Data Tracking

TempraMed Announces VIVI Cap Smart Connectivity with Apple Health and Google Fit, Providing Better Health Outcomes and Data Tracking

TempraMed Technologies Raises $1.2 Million Via Non-Brokered Private Placement

TempraMed Technologies Raises $1.2 Million Via Non-Brokered Private Placement

TempraMed Technologies Ltd. Announces Closing of Private Placement

TempraMed Technologies Ltd. Announces Closing of Private Placement

TempraMed Signs Letter of Intent with CPO Cyprus for Exclusive Distribution of VIVI Products in Cyprus

TempraMed Signs Letter of Intent with CPO Cyprus for Exclusive Distribution of VIVI Products in Cyprus

TempraMed Announces Distribution Agreement with CenterWell Pharmacy(R), the Pharmacy Services Brand of Humana

TempraMed Reports Record July Sales and Strong August Performance, with Year-to-Date Sales Already Exceeding Full-Year 2025 Revenue

TempraMed Reports Record July Sales and Strong August Performance, with Year-to-Date Sales Already Exceeding Full-Year 2025 Revenue

TempraMed Signs Letter of Intent with CPO Greece for Exclusive Distribution of VIVI Products in Greece

TempraMed Signs Letter of Intent with CPO Greece for Exclusive Distribution of VIVI Products in Greece

TempraMed Signs Definitive Five-Year Saudi Arabia Distribution Agreement for Private-Label VIVI Cap

TempraMed Signs Definitive Five-Year Saudi Arabia Distribution Agreement for Private-Label VIVI Cap

TempraMed Announces Extension of Maccabi Healthcare Services Agreement

TempraMed Announces Extension of Maccabi Healthcare Services Agreement

Mobilize your Website

View Site in Mobile | Classic

Share by: